CYMABAY THERAPEUTICS INC shareholders Q3 2023

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Caption Management, LLC 536,100$7,993,2510.12%
Corton Capital Inc. 16,080$239,7530.12%
Bayesian Capital Management, LP 67,400$1,004,9340.12%
Caption Management, LLC 490,600$7,314,8460.11%
Point72 Asset Management, L.P. 2,429,924$36,230,1670.11%
Virtus ETF Advisers LLC 11,343$169,1240.10%
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 38,894$579,9100.10%
Atom Investors LP 24,538$365,8620.08%
Trexquant Investment LP 219,755$3,276,5470.08%
ClariVest Asset Management LLC 96,481$1,4380.08%
J. Goldman & Co LP 138,949$2,071,7300.07%
SEVEN EIGHT CAPITAL, LP 41,556$619,6000.07%
Woodline Partners LP 410,715$6,123,7610.07%
J. Goldman & Co LP 135,000$2,012,8500.07%
Hennion & Walsh Asset Management, Inc. 72,839$1,086,0290.07%
JANUS HENDERSON GROUP PLC 6,803,484$101,432,0210.07%
ALGERT GLOBAL LLC 92,886$1,3850.06%
Campbell & CO Investment Adviser LLC 36,115$538,4750.06%
XTX Topco Ltd 18,576$276,9680.05%
JENNISON ASSOCIATES LLC 3,555,274$53,009,1350.04%
External links

This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.